Aldeyra Therapeutics (ALDX) Posts Q1 Loss of $1.56/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($1.56), $1.03 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
• Strategy to report Q2 2026 results on July 30
• Piper Sandler Reiterates Overweight Rating on Reddit (RDDT)